Table 1. Association between CHD1L expression and various clinicopathological variables of patients with EC (Chi-square test).
Variable | All cases (n=191) | CHD1L protein expression | P value | |
---|---|---|---|---|
Low expression (n=105) | High expression (n=86) | |||
Gender | 0.068 | |||
Female | 50 | 33 | 17 | |
Male | 141 | 72 | 69 | |
Age at surgery | 0.695 | |||
<60 | 125 | 70 | 55 | |
≥60 | 66 | 35 | 31 | |
Histology type | 0.428 | |||
Ulcerating-type | 68 | 33 | 35 | |
Medullary-type | 74 | 46 | 28 | |
Fungating-type | 38 | 20 | 18 | |
Stricture-type | 11 | 6 | 5 | |
Clinical stages | 0.003* | |||
I | 19 | 15 | 4 | |
II | 75 | 47 | 28 | |
III | 42 | 23 | 19 | |
IV | 55 | 20 | 35 | |
Differentiation | 0.590 | |||
Poor | 36 | 18 | 18 | |
Mediate | 127 | 70 | 57 | |
Well | 27 | 17 | 10 | |
Tumor location | 0.656 | |||
Upper | 27 | 14 | 13 | |
Middle | 140 | 80 | 60 | |
Lower | 23 | 11 | 12 | |
Tumor size(cm) | 0.612 | |||
<4 | 39 | 25 | 14 | |
≥4 | 152 | 80 | 72 | |
Lymph node metastasis | 0.000* | |||
None | 90 | 27 | 63 | |
<4 | 35 | 23 | 12 | |
≥4 | 66 | 55 | 11 |
* P < 0.05 was considered significant.